Zamboni Group
Our lab is interested in metabolism: how it's regulated, how it drives cellular decisions or differentiation, and how it sustains pathological states in disease.
Metabolomics at scale
To address these questions across biological systems, we adopt a data-driven approach that heavily relies on mass spectrometry. One of our core expertise is high-throughput metabolomics (and lipidomics), which we routinely employ to characterize in-depth sample cohorts of virtually any size (100'000+) samples. We employ largely automatized workflows that are optimized to combine sensitivity, scalability, and robustness.
Our methods are under continuous development. We employ instruments of the latest generation and dedicate substantial R&D activity to steadily improve the detail, the scope, the confidence, the sensitivity, or the speed of analyses. For instance, to date we work on non-canonical dissociation techniques (EAD/EID, UVPD) for structural elucidation, the comprehensive annotation of complex samples, or the injection of metabolomics data in knowledge graphs and AI/DL models.
Our lab hosts the PHRT Center for Clinical Metabolomics and Lipidomics - associated to the Swiss Multi-Omics Center (SMOC) - and is involved in multiple National and local consortia on personalized health.
From data to insights
Profiling metabolite - or lipid - levels is very effective for discovery, but rarely sufficient to derive a conclusive or causal information. Therefore, we develop computational approaches and models to infer regulatory causality from the observable data (e.g. metabolomics and proteomics, stationary and dynamic) or quantify fluxes by 13C stable isotopic tracers. In particular, we strive to develop generally applicable methods that can cope with the complexity of mammalian cells and use prior knowledge to compensate for the cronic lack of data.
Our toolbox is applied broadly on very different systems (microbes, worms, cell lines, mice, primary human cells and tissues, etc.) through a large network of collaborators in Academia and Industry.
FAQs:
Blog
external page On the benefits and role of electron-induced dissociation in lipidomics
external page Why do we prefer TOFs over Orbitraps for flow injection analysis?
external page All-inclusive, turnkey processing for untargeted LC-MS
external page MSNovelist:The journey towards de novo structure elucidation
Mass Spectrometry in the Life Sciences Award 2024 to Nicola Zamboni

The prize by the German Society of Mass Spectrometry (DGMS) honors outstanding method developments in and applications of mass spectrometry in the life sciences.
Sauer Zamboni group achieves LEAF sustainability certification!

The group was one of 19 labs across ETH Zurich to be certified in the LEAF pilot project.
Congratulations to Stephan Durot for passing his PhD defense
Stephan's thesis pivots on the integrated analysis of endothelial cells from different vascular beds.
Adriano Rutz wins the Gold Trophy of the National ORD Prize 2023! Well done!

The prize is awarded by the Swiss Academies of Arts and Sciences in recognition of innovative and impactful practices in the field of Open Research Data (ORD).
Tomek Diederen defends his PhD Thesis
We congratulate Tomek for successfully defending his thesis on "Simulation-based metabolic flux inference" which, by his own words, all boils down to clouds vs. points. Well done!